Odyssey Therapeutics, Inc.
ODTX
15 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 5:10 PM | TPG GP A, LLCOther | Purchase | 1,388,889 | $18.00 | $25.0M | 3,690,146(I) | View → |
| May 8, 2026 | May 12 5:37 PM | Dimension Capital II, L.P.Director | Purchase | 1,111,111 | $18.00 | $20.0M | 3,333,516(D) | View → |
| May 11, 2026 | May 11 9:11 PM | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Purchase | 555,555 | $18.00 | $10.0M | 1,014,851(I) | View → |
| May 11, 2026 | May 11 9:11 PM | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Sale | 1,780 | $18.00 | $32.0K | 814,851(I) | View → |
| May 8, 2026 | May 11 8:35 PM | Jeffrey M LeidenDirector | Purchase | 5,000 | $20.00 | $100.0K | 270,198(D) | View → |
| May 8, 2026 | May 11 8:32 PM | Jason HaasChief Financial Officer | Purchase | 1,000 | $20.00 | $20.0K | 62,908(D) | View → |
| May 11, 2026 | May 11 8:30 PM | Nan (Ln) LiDirector | Purchase | 1,111,111 | $18.00 | $20.0M | 3,333,516(I) | View → |
| May 11, 2026 | May 11 8:30 PM | Shelley ChuDirector | Purchase | 11,111 | $18.00 | $200.0K | 11,111(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 5:10 PM | TPG GP A, LLCOther | Conversion | 18,272,789 | — | 0(I) | View → |
| May 11, 2026 | May 13 5:10 PM | TPG GP A, LLCOther | Other (J) | 423,111 | — | 0(I) | View → |
| May 8, 2026 | May 12 5:37 PM | Dimension Capital II, L.P.Director | Conversion | 16,611,626 | — | 0(D) | View → |
| May 11, 2026 | May 11 9:11 PM | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 28,094,171 | — | 0(I) | View → |
| May 11, 2026 | May 11 9:11 PM | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | X | 3,109,918 | $0.10 | 0(I) | View → |
| May 11, 2026 | May 11 8:35 PM | Jeffrey M LeidenDirector | Conversion | 275,168 | — | 0(I) | View → |
| May 11, 2026 | May 11 8:35 PM | Jeffrey M LeidenDirector | Option Exercise | 28,800 | $0.10 | 0(I) | View → |
| May 7, 2026 | May 11 8:35 PM | Jeffrey M LeidenDirector | Grant/Award | 626,220 | $18.00 | 626,220(D) | View → |
| May 11, 2026 | May 11 8:30 PM | Nan (Ln) LiDirector | Conversion | 16,611,626 | — | 0(I) | View → |
| May 7, 2026 | May 11 8:30 PM | Ian F SmithDirector | Grant/Award | 27,393 | $18.00 | 27,393(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Valerie OdegardDirector | Grant/Award | 27,393 | $18.00 | 27,393(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Ourania TatsisDirector | Grant/Award | 27,393 | $18.00 | 27,393(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Natalie DalesChief of Research Operations and Portfolio Strategy | Grant/Award | 79,773 | $18.00 | 79,773(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Timothy P WalbertDirector | Grant/Award | 27,393 | $18.00 | 27,393(D) | View → |
| May 11, 2026 | May 11 8:30 PM | Gary D GlickDirector, President and Chief Executive Officer | Conversion | 266,116 | — | 0(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Gary D GlickDirector, President and Chief Executive Officer | Grant/Award | 884,450 | $18.00 | 884,450(D) | View → |
| May 11, 2026 | May 11 8:30 PM | Anthony W. OpipariInterim Chief Medical Officer and Executive Vice President, Translational Medicine | Conversion | 67,159 | — | 0(D) | View → |
| May 11, 2026 | May 11 8:30 PM | Anthony W. OpipariInterim Chief Medical Officer and Executive Vice President, Translational Medicine | Option Exercise | 5,263 | $0.10 | 0(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Anthony W. OpipariInterim Chief Medical Officer and Executive Vice President, Translational Medicine | Grant/Award | 277,980 | $18.00 | 27,777(D) | View → |
| May 7, 2026 | May 11 8:30 PM | Collin M ToddSenior Vice President, Strategy and Business Development | Grant/Award | 93,904 | $18.00 | 93,904(D) | View → |